Black Hawk Acquisition (BKHA) Stock: Why It's Down Today
Updated Oct 19, 2026, 4:00 PM ET · closing price
- Closed at $4.03, -32.95% vs the prior close of $6.01.
- Volume 74.45K shares, 2.6x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BKHA slides 32.9% to $4.03, a 52-week low on 4.7x normal volume. Closed at $4.03, -32.95% vs the prior close of $6.01. Day range $3.70–$5.93, opened at $5.93.
BKHA daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — BKHA slides 32.9% to $4.03, a 52-week low on 4.7x normal volume
- Closed at $4.03, -32.95% vs the prior close of $6.01. Day range $3.70–$5.93, opened at $5.93.
- Volume was 74.45K shares, 4.7x its 50-day average of 15.75K — unusually heavy trading.
- Price is -65.2% vs its 50-day average ($11.58) and -65.5% vs its 200-day average ($11.69).
- 52-week range $3.70–$23.00; today's close sits at 2% of that range, 82.5% below the 52-week high.
- That makes 5 straight losses.
Oct 16, 2026 — BKHA slides 12.3% to $6.01, a 52-week low, 4 down days in a row
- Closed at $6.01, -12.26% vs the prior close of $6.85. Day range $5.90–$7.18, opened at $6.74.
- Volume was 13.38K shares, 0.9x its 50-day average of 15.48K.
- Price is -48.8% vs its 50-day average ($11.74) and -48.7% vs its 200-day average ($11.72).
- 52-week range $5.47–$23.00; today's close sits at 3% of that range, 73.9% below the 52-week high.
- That makes 4 straight losses.
Oct 15, 2026 — BKHA slides 11.5% to $6.85, a 52-week low on 1.8x normal volume
- Closed at $6.85, -11.50% vs the prior close of $7.74. Day range $6.34–$7.61, opened at $7.50.
- Volume was 27.30K shares, 1.8x its 50-day average of 14.93K — unusually heavy trading.
- Price is -42.2% vs its 50-day average ($11.85) and -41.7% vs its 200-day average ($11.75).
- 52-week range $5.47–$23.00; today's close sits at 8% of that range, 70.2% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 — BKHA slides 38.0% to $7.74, a 52-week low on 11.6x normal volume
- Closed at $7.74, -37.98% vs the prior close of $12.48. Day range $5.47–$10.75, opened at $10.75.
- Volume was 140.80K shares, 11.6x its 50-day average of 12.12K — unusually heavy trading.
- Price is -35.2% vs its 50-day average ($11.95) and -34.2% vs its 200-day average ($11.77).
- 52-week range $5.47–$23.00; today's close sits at 13% of that range, 66.3% below the 52-week high.
Oct 13, 2026 — BKHA slides 4.0% to $12.48 on 25.6x normal volume
- Closed at $12.48, -4.00% vs the prior close of $13.00. Day range $9.50–$13.77, opened at $12.99.
- Volume was 205.20K shares, 25.6x its 50-day average of 8.01K — unusually heavy trading.
- Price is +3.7% vs its 50-day average ($12.03) and +5.9% vs its 200-day average ($11.79).
- 52-week range $9.50–$23.00; today's close sits at 22% of that range, 45.7% below the 52-week high.
- SEC filings that day: 8-K.
Oct 12, 2026 — BKHA jumps 12.7% to $13.00 on 6.3x normal volume
- Closed at $13.00, +12.75% vs the prior close of $11.53. Day range $11.95–$23.00, opened at $11.95.
- Volume was 44.80K shares, 6.3x its 50-day average of 7.12K — unusually heavy trading.
- Price is +8.2% vs its 50-day average ($12.02) and +10.3% vs its 200-day average ($11.78).
- 52-week range $11.00–$23.00; today's close sits at 17% of that range, 43.5% below the 52-week high.
Oct 9, 2026 — BKHA slides 6.5% to $11.53, a 6-month low
- Closed at $11.53, -6.49% vs the prior close of $12.33. Day range $11.53–$12.50, opened at $12.50.
- Volume was 2.00K shares, 0.3x its 50-day average of 7.25K — lighter than usual.
- Price is -3.9% vs its 50-day average ($11.99) and -2.1% vs its 200-day average ($11.77).
- 52-week range $11.00–$13.15; today's close sits at 25% of that range, 12.3% below the 52-week high.
Oct 8, 2026 — BKHA slides 5.2% to $12.33 on 31.5x normal volume
- Closed at $12.33, -5.15% vs the prior close of $13.00. Day range $12.00–$13.00, opened at $12.97.
- Volume was 140.20K shares, 31.5x its 50-day average of 4.45K — unusually heavy trading.
- Price is +2.8% vs its 50-day average ($12.00) and +4.8% vs its 200-day average ($11.77).
- 52-week range $11.00–$13.15; today's close sits at 62% of that range, 6.2% below the 52-week high.
Oct 7, 2026 — BKHA jumps 5.9% to $13.00, a 1-month high
- Closed at $13.00, +5.86% vs the prior close of $12.28. Day range $12.25–$13.15, opened at $12.25.
- Volume was 7.30K shares, 1.7x its 50-day average of 4.36K.
- Price is +8.4% vs its 50-day average ($11.99) and +10.5% vs its 200-day average ($11.77).
- 52-week range $11.00–$13.15; today's close sits at 93% of that range, 1.1% below the 52-week high.
Oct 6, 2026 — BKHA ends flat (+0.0%) to $12.28
- Closed at $12.28, +0.00% vs the prior close of $12.28. Day range $12.28–$12.28, opened at $12.28.
- Price is +2.5% vs its 50-day average ($11.98) and +4.5% vs its 200-day average ($11.76).
- 52-week range $11.00–$13.10; today's close sits at 61% of that range, 6.3% below the 52-week high.
- SEC filings that day: 10-Q.
Oct 5, 2026 — BKHA dips 0.8% to $12.28
- Closed at $12.28, -0.81% vs the prior close of $12.38. Day range $12.28–$12.41, opened at $12.41.
- Volume was 1.30K shares, 0.3x its 50-day average of 4.34K — lighter than usual.
- Price is +2.6% vs its 50-day average ($11.97) and +4.5% vs its 200-day average ($11.75).
- 52-week range $11.00–$13.10; today's close sits at 61% of that range, 6.3% below the 52-week high.
Oct 2, 2026 — BKHA ends flat (+0.2%) to $12.38, a 1-month high on 2.5x normal volume
- Closed at $12.38, +0.24% vs the prior close of $12.35. Day range $12.20–$12.62, opened at $12.62.
- Volume was 10.30K shares, 2.5x its 50-day average of 4.14K — unusually heavy trading.
- Price is +3.4% vs its 50-day average ($11.97) and +5.4% vs its 200-day average ($11.75).
- 52-week range $11.00–$13.10; today's close sits at 66% of that range, 5.5% below the 52-week high.
BKHA bull case vs bear case (from the data)
- Latest fiscal-year net income: profit of $1.33M.
- Price is -65.2% vs its 50-day average — short-term trend is down.
- Price is -65.5% vs its 200-day average — below the long-term trend line.
- High volatility: average daily move of 6.7% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
BKHA latest news & SEC filings
Every SEC filing by or about BKHA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Oct 7, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Aug 31, 2026:
- Net income: $1.07M (prior year $154.40K) (+596.1% vs Aug 31, 2025)
Sep 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
Sep 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 22, 2026 · Form 424B4 — Final prospectus with offering price
Final prospectus with offering price
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 17, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 26, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
- Item 3.02 — Sold unregistered shares.
Aug 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 15, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended May 31, 2026:
- Net income: $88.93K (prior year $520.54K) (-82.9% vs May 31, 2025)
Things to know before you trade BKHA
- How much it moves: over the last 20 sessions the average daily move was 6.66% (largest 38.0%). That is a volatile stock.
- Liquidity: about 42.51K shares (≈$171.30K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $4.03 vs a range of $3.70–$23.00 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 13, 2026; 10-Q Oct 6, 2026; 8-K Sep 24, 2026.
- Share count: 4.15M shares outstanding (Oct 6, 2026), +0.0% vs a year earlier.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
BKHA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 5.93 | 5.93 | 3.70 | 4.03 | 74.45K |
| Oct 16, 2026 | 6.74 | 7.18 | 5.88 | 6.01 | 13.40K |
| Oct 15, 2026 | 7.50 | 7.61 | 6.34 | 6.85 | 27.30K |
| Oct 14, 2026 | 10.75 | 10.75 | 5.47 | 7.74 | 140.80K |
| Oct 13, 2026 | 12.99 | 13.77 | 9.50 | 12.48 | 205.20K |
| Oct 12, 2026 | 11.95 | 23.00 | 11.95 | 13.00 | 44.80K |
| Oct 9, 2026 | 12.50 | 12.50 | 11.53 | 11.53 | 2.00K |
| Oct 8, 2026 | 12.97 | 13.00 | 12.00 | 12.33 | 140.20K |
| Oct 7, 2026 | 12.25 | 13.15 | 12.25 | 13.00 | 7.30K |
| Oct 6, 2026 | 12.28 | 12.28 | 12.28 | 12.28 | 0 |
| Oct 5, 2026 | 12.41 | 12.41 | 12.28 | 12.28 | 1.30K |
| Oct 2, 2026 | 12.62 | 12.62 | 12.20 | 12.38 | 10.30K |
| Oct 1, 2026 | 12.35 | 12.35 | 12.35 | 12.35 | 0 |
| Sep 30, 2026 | 12.31 | 12.95 | 12.31 | 12.35 | 1.70K |
| Sep 29, 2026 | 12.62 | 12.62 | 12.31 | 12.36 | 1.30K |
| Sep 28, 2026 | 12.30 | 12.35 | 12.30 | 12.31 | 157.20K |
| Sep 25, 2026 | 12.27 | 12.27 | 12.27 | 12.27 | 14.10K |
| Sep 24, 2026 | 12.19 | 12.19 | 12.19 | 12.19 | 500 |
| Sep 23, 2026 | 12.10 | 12.10 | 12.10 | 12.10 | 0 |
| Sep 22, 2026 | 11.98 | 12.10 | 11.88 | 12.10 | 8.30K |
About Black Hawk Acquisition
Black Hawk Acquisition (BKHA) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in DANVILLE, CA. Fiscal year ends November 30. SEC CIK 2000775.
BKHA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
BKHA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Nov 30, 2025 | — | $1.33M | — | $-650.32K |
| Nov 30, 2024 | — | $1.92M | — | $-553.66K |
Latest balance sheet: total assets $26.03M, total liabilities $4.75M, cash $0 (as of Aug 31, 2026).
BKHA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Biogen (BIIB)Halozyme Therapeutics (HALO)Vaxcyte (PCVX)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on BKHA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.